As of 2026-09-16, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (25.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -536.7%.
The range of the Relative Valuation is (22.41) - (28.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 29.7x | 26.4x |
| Forward P/E multiples | 23.3x - 30.4x | 26.8x |
| Fair Price | (22.41) - (28.57) | (25.63) |
| Upside | -481.8% - -586.7% | -536.7% |
| Date | P/E |